GSEA revealed significant enrichment in the non-alcoholic fatty liver disease, staphylococcus aureus infection, systemic lupus erythematosus, asthma, intestinal immune network for IgA production, and apoptosis (Figure 4). Here, CD79A is linked to metabolic dysfunction-associated steatotic liver disease.